Comparison of Expected Imaging Findings Following Percutaneous Microwave and Cryoablation of Pulmonary Tumors: Ablation Zones and Thoracic Lymph Nodes

Overview

Journal Eur Radiol

Specialty Radiology

Date 2022 Jun 15

PMID 35704108

Authors

Maria M Wrobel

Alexis M Cahalane

Dessislava Pachamanova

Konstantin S Leppelmann

Stuart G Silverman

Amita Sharma

Paul B Shyn

Nathaniel D Mercaldo

Florian J Fintelmann

Affiliations

Soon will be listed here.

Abstract

Objective: To compare temporal changes of ablation zones and lymph nodes following lung microwave ablation (MWA) and cryoablation.

Methods: This retrospective cohort study compared lung ablation zones and thoracic lymph nodes following MWA and cryoablation performed 2006-2020. In the ablation zone cohort, ablation zone volumes were measured on serial CT for 12 months. In the lymph node cohort, the sum of bidimensional products of lymph node diameters was measured before (baseline) and up to 6 months following ablation. Cumulative incidence curves estimated the time to 75% ablation zone reduction and linear mixed-effects regression models compared the temporal distribution of ablation zones and lymph node sizes between modalities.

Results: Ablation zones of 59 tumors treated in 45 sessions (16 MWA, 29 cryoablation) in 36 patients were evaluated. Differences in the time to 75% volume reduction between modalities were not detected. Following MWA, half of the ablation zones required an estimated time of 340 days to achieve a 75% volume reduction compared to 214 days following cryoablation (p = .30). Thoracic lymph node sizes after 33 sessions (13 MWA, 20 cryoablation) differed between modalities (baseline-32 days, p = .01; 32-123 days, p = .001). Following MWA, lymph nodes increased on average by 38 mm (95%CI, 5.0-70.7; p = .02) from baseline to 32 days, followed by an estimated decrease of 50 mm (32-123 days; p = .001). Following cryoablation, changes in lymph nodes were not detected (baseline-32 days, p = .33).

Conclusion: The rate of ablation zone volume reduction did not differ between MWA and cryoablation. Thoracic lymph nodes enlarged transiently after MWA but not after cryoablation.

Key Points: • Contrary to current belief, the rate of lung ablation zone volume reduction did not differ between microwave and cryoablation. • Transient enlargement of thoracic lymph nodes after microwave ablation was not associated with regional tumor spread and decreased within six months following ablation. • No significant thoracic lymph node enlargement was observed following cryoablation.

Citing Articles

Cryoablation-induced modulation of Treg cells and the TGF-β pathway in lung adenocarcinoma: implications for increased antitumor immunity.

Lin S, Liu D, Liang T, Zhuang Y, Wang X, Ma S BMC Med. 2025; 23(1):89.

PMID: 39948553 PMC: 11827211. DOI: 10.1186/s12916-025-03926-1.

Leveraging deep learning for more accurate prediction of lung microwave ablation zones.

Graur A, Alici C, Fintelmann F Eur Radiol. 2024; 34(11):7159-7160.

PMID: 39075303 DOI: 10.1007/s00330-024-10995-y.

Imaging Follow-Up of Nonsurgical Therapies for Lung Cancer: Expert Panel Narrative Review.

Murphy D, Mayoral M, Larici A, Ginsberg M, Cicchetti G, Fintelmann F AJR Am J Roentgenol. 2023; 221(4):409-424.

PMID: 37095669 PMC: 11037936. DOI: 10.2214/AJR.23.29104.

References

De Baere T, Tselikas L, Woodrum D, Abtin F, Littrup P, Deschamps F . Evaluating Cryoablation of Metastatic Lung Tumors in Patients--Safety and Efficacy: The ECLIPSE Trial--Interim Analysis at 1 Year. J Thorac Oncol. 2015; 10(10):1468-74. DOI: 10.1097/JTO.0000000000000632. View

Moore W, Talati R, Bhattacharji P, Bilfinger T . Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol. 2015; 26(3):312-9. DOI: 10.1016/j.jvir.2014.12.006. View

Palussiere J, Catena V, Buy X . Percutaneous thermal ablation of lung tumors - Radiofrequency, microwave and cryotherapy: Where are we going?. Diagn Interv Imaging. 2017; 98(9):619-625. DOI: 10.1016/j.diii.2017.07.003. View

Leppelmann K, Levesque V, Bunck A, Cahalane A, Lanuti M, Silverman S . Outcomes Following Percutaneous Microwave and Cryoablation of Lung Metastases from Adenoid Cystic Carcinoma of the Head and Neck: A Bi-Institutional Retrospective Cohort Study. Ann Surg Oncol. 2021; 28(11):5829-5839. DOI: 10.1245/s10434-021-09714-4. View

Fintelmann F, Braun P, Mirzan S, Huang A, Best T, Keyes C . Percutaneous Cryoablation: Safety and Efficacy for Pain Palliation of Metastases to Pleura and Chest Wall. J Vasc Interv Radiol. 2020; 31(2):294-300. DOI: 10.1016/j.jvir.2019.09.013. View

Dupuy D . Image-guided thermal ablation of lung malignancies. Radiology. 2011; 260(3):633-55. DOI: 10.1148/radiol.11091126. View

Ito N, Nakatsuka S, Inoue M, Yashiro H, Oguro S, Izumi Y . Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. J Vasc Interv Radiol. 2012; 23(8):1043-52. DOI: 10.1016/j.jvir.2012.04.033. View

Chheang S, Abtin F, Guteirrez A, Genshaft S, Suh R . Imaging Features following Thermal Ablation of Lung Malignancies. Semin Intervent Radiol. 2014; 30(2):157-68. PMC: 3709948. DOI: 10.1055/s-0033-1342957. View

Abtin F, De Baere T, Dupuy D, Genshaft S, Healey T, Khan S . Updates on Current Role and Practice of Lung Ablation. J Thorac Imaging. 2019; 34(4):266-277. DOI: 10.1097/RTI.0000000000000417. View

10.

Prudhomme C, Deschamps F, Moulin B, Hakime A, Al-Ahmar M, Moalla S . Image-guided lung metastasis ablation: a literature review. Int J Hyperthermia. 2019; 36(2):37-45. DOI: 10.1080/02656736.2019.1647358. View

11.

Wei Z, Ye X, Yang X, Zheng A, Huang G, Li W . Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer. Cardiovasc Intervent Radiol. 2014; 38(1):135-42. DOI: 10.1007/s00270-014-0895-0. View

12.

Herrera L, Fernando H, Perry Y, Gooding W, Buenaventura P, Christie N . Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg. 2003; 125(4):929-37. DOI: 10.1067/mtc.2003.18. View

13.

Lyons G, Askin G, Pua B . Clinical Outcomes after Pulmonary Cryoablation with the Use of a Triple Freeze Protocol. J Vasc Interv Radiol. 2018; 29(5):714-721. DOI: 10.1016/j.jvir.2017.12.029. View

14.

Vogl T, Naguib N, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin N . Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology. 2011; 261(2):643-51. DOI: 10.1148/radiol.11101643. View

15.

Al-Hakim R, Abtin F, Genshaft S, Kutay E, Suh R . Defining New Metrics in Microwave Ablation of Pulmonary Tumors: Ablation Work and Ablation Resistance Score. J Vasc Interv Radiol. 2016; 27(9):1380-1386. DOI: 10.1016/j.jvir.2016.05.026. View

16.

Deandreis D, Leboulleux S, Dromain C, Auperin A, Coulot J, Lumbroso J . Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation. Radiology. 2010; 258(1):270-6. DOI: 10.1148/radiol.10092440. View

17.

Abtin F, Eradat J, Gutierrez A, Lee C, Fishbein M, Suh R . Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics. 2012; 32(4):947-69. PMC: 3393883. DOI: 10.1148/rg.324105181. View

18.

Sharma A, Digumarthy S, Kalra M, Lanuti M, Shepard J . Reversible locoregional lymph node enlargement after radiofrequency ablation of lung tumors. AJR Am J Roentgenol. 2010; 194(5):1250-6. DOI: 10.2214/AJR.09.3206. View

19.

Wolf F, Grand D, Machan J, DiPetrillo T, Mayo-Smith W, Dupuy D . Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008; 247(3):871-9. DOI: 10.1148/radiol.2473070996. View

20.

Ahmed M . Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update: supplement to the consensus document. J Vasc Interv Radiol. 2014; 25(11):1706-8. DOI: 10.1016/j.jvir.2014.09.005. View